Keeping Track: Novartis Scores Big Ahead Of US Memorial Day With Approvals For Gene Therapy Zolgensma, Oncologic Piqray

 
• By Michael Cipriano, Brenda Sandburg, and Bridget Silverman

The latest drug development news and highlights from our US FDA Performance Tracker. 

Keeping Track Feature image
Novartis stole the spotlight with the FDA's approval for its gene therapy Zolgensma.

More from Product Reviews

More from Pink Sheet